AU6486096A - Pharmaceutical compositions containing alpha-keto carboxylates - Google Patents

Pharmaceutical compositions containing alpha-keto carboxylates

Info

Publication number
AU6486096A
AU6486096A AU64860/96A AU6486096A AU6486096A AU 6486096 A AU6486096 A AU 6486096A AU 64860/96 A AU64860/96 A AU 64860/96A AU 6486096 A AU6486096 A AU 6486096A AU 6486096 A AU6486096 A AU 6486096A
Authority
AU
Australia
Prior art keywords
pharmaceutical compositions
compositions containing
containing alpha
carboxylates
keto
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU64860/96A
Inventor
Rolf Bunger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Army
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU6486096A publication Critical patent/AU6486096A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU64860/96A 1996-05-08 1996-07-12 Pharmaceutical compositions containing alpha-keto carboxylates Abandoned AU6486096A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64328496A 1996-05-08 1996-05-08
US08643284 1996-05-08
PCT/US1996/011434 WO1997041848A1 (en) 1996-05-08 1996-07-12 Pharmaceutical compositions containing alpha-keto carboxylates

Publications (1)

Publication Number Publication Date
AU6486096A true AU6486096A (en) 1997-11-26

Family

ID=24580143

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64860/96A Abandoned AU6486096A (en) 1996-05-08 1996-07-12 Pharmaceutical compositions containing alpha-keto carboxylates

Country Status (2)

Country Link
AU (1) AU6486096A (en)
WO (1) WO1997041848A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6242491B1 (en) 1999-06-25 2001-06-05 Rima Kaddurah-Daouk Use of creatine or creatine compounds for skin preservation
US6846842B2 (en) 1999-10-07 2005-01-25 Beth Israel Deconess Medical Center, Inc. Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion
FR3035407B1 (en) 2015-04-23 2022-06-17 Francais Du Sang Ets METHOD FOR PRESERVING CELLS, TISSUES OR ORGANS IN HYPOTHERMIA
FR3040860B1 (en) 2015-09-10 2020-05-15 Universite de Bordeaux INJECTABLE STORAGE MEDIUM FOR STORAGE OF PLACENTAL BLOOD, BONE MARROW AND PERIPHERAL BLOOD CELLS
WO2021229467A1 (en) * 2020-05-12 2021-11-18 M.T.K. Medical Center Limited Liability Company Combined hyperosmolar solution for infusion

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB615323A (en) * 1945-11-12 1949-01-05 Alfred Kraus M D Process for reducing the viscosity of or for liquefying mucus, and preparations for use therein
DE3273611D1 (en) * 1982-11-10 1986-11-13 Laevosan Gmbh & Co Kg Infusion solutions for heart therapy
ATE82500T1 (en) * 1984-06-22 1992-12-15 Richard L Veech ELECTROLYTE SOLUTIONS AND THEIR (IN VIVO) USE.
AU8539491A (en) * 1990-09-21 1992-04-15 Regents Of The University Of Minnesota Pyruvate solutions to counteract acute renal failure
CA2123678A1 (en) * 1991-11-26 1993-06-10 Alain Martin Wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids
CA2129732A1 (en) * 1992-02-25 1993-09-02 Alain Martin Cytoprotective compositions containing pyruvate and antioxidants
US5536751A (en) * 1994-05-09 1996-07-16 The United States Of America As Represented By The Secretary Of The Army Pharmaceutical alpha-keto carboxylic acid compositions method of making and use thereof
US5480909A (en) * 1994-08-08 1996-01-02 University Of Pittsburgh Medical Center Method for inhibiting generation of free-radicals

Also Published As

Publication number Publication date
WO1997041848A1 (en) 1997-11-13

Similar Documents

Publication Publication Date Title
AU4762797A (en) Pharmaceutical compositions
AU2967597A (en) Pharmaceutical compositions
AU1875997A (en) Pharmaceutical composition for immunomodulation
AU6216296A (en) Pharmaceutical compositions
AU5136998A (en) Medicinal composition
AU3716193A (en) Pharmaceutical compositions
AU5317598A (en) Novel pharmaceutical compositions
AU3777897A (en) Pharmaceutical compositions
AU8107998A (en) Pharmaceutical compositions
AU6370299A (en) Pharmaceutical compositions containing tetrahydroisoquinoline compounds
GB9610359D0 (en) Pharmaceutical compositions
AU7904998A (en) Pharmaceutical composition containing peptichemio
AU4330097A (en) Pharmaceutical compounds
AU5274096A (en) Pharmaceutical compositions
AUPN933396A0 (en) Non-aqueuos oral-drench compositions containing avermectin compounds
AU2531295A (en) Pharmaceutical composition
AU5326298A (en) Pharmaceutical compositions containing N-sulphonylindoline derivatives
AU3942297A (en) Pharmaceutical compositions containing 4-oxobutanoic acids
AU3460897A (en) Medicinal compositions
AU6486096A (en) Pharmaceutical compositions containing alpha-keto carboxylates
AU4169897A (en) Pharmaceutical compounds
AUPP332898A0 (en) Pharmaceutical composition
GB9606429D0 (en) Pharmaceutical compositions
AU4326197A (en) Pharmaceutical compositions
AUPN862596A0 (en) Pharmaceutical compositions